Method for producing artificial recombinant RNA virus stably retaining foreign gene

US12305192B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12305192-B2
Application numberUS-202017619899-A
CountryUS
Kind codeB2
Filing dateJun 19, 2020
Priority dateJun 21, 2019
Publication dateMay 20, 2025
Grant dateMay 20, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a method for producing an artificial recombinant RNA virus stably expressing a foreign gene, comprising the steps of:(1) obtaining a foreign gene having a modified codon composition similar to that of an RNA virus gene;(2) inserting the foreign gene obtained in step (1) into an RNA virus genome; and(3) artificially synthesizing an artificial recombinant RNA virus using reverse genetics.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing an artificial recombinant RNA virus stably retaining a foreign gene, comprising the steps of: (1) obtaining a foreign gene having a codon composition modified to such an extent that the difference in the codon composition between the foreign gene and an RNA virus gene is within +30%; (2) inserting the foreign gene obtained in step ( 1 ) into an RNA virus genome; and (3) artificially synthesizing an artificial recombinant RNA virus using reverse genetics, wherein the RNA virus is a virus belonging to the family Reoviridae. 2. The method according to claim 1 , wherein the virus belonging to the family Reoviridae is a virus belonging to the genus Rotavirus or Orthoreovirus. 3. A method for enabling stable retention of an introduced foreign gene in an artificial recombinant RNA virus artificially synthesized using reverse genetics, comprising modifying the codon composition of a foreign gene to such an extent that the difference in the codon composition between the foreign gene and an RNA virus gene is within +30%, wherein the RNA virus is a virus belonging to the family Reoviridae. 4. The method according to claim 3 , wherein the virus belonging to the family Reoviridae is a virus belonging to the genus Rotavirus or Orthoreovirus.

Assignees

Inventors

Classifications

  • viral genome or elements thereof as genetic vector · CPC title

  • New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes · CPC title

  • Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title

  • Vectors comprising a coding region that has been codon optimised for expression in a respective host · CPC title

  • C12N15/867Primary

    Retroviral vectors · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12305192B2 cover?
Provided is a method for producing an artificial recombinant RNA virus stably expressing a foreign gene, comprising the steps of:(1) obtaining a foreign gene having a modified codon composition similar to that of an RNA virus gene;(2) inserting the foreign gene obtained in step (1) into an RNA virus genome; and(3) artificially synthesizing an artificial recombinant RNA virus using reverse genet…
Who is the assignee on this patent?
Univ Osaka
What technology area does this patent fall under?
Primary CPC classification C12N15/867. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).